Relationship between the Autoantibody and Expression of β3-Adrenoceptor in Lung and Heart
Open Access
- 5 July 2013
- journal article
- retracted article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (7) , e68747
Abstract
Evidences suggest that β3-adrenoceptor (β3-AR) plays an important role in heart failure (HF), although no data is reported indicating how these effects may change with the increasing age. Pulmonary congestion and edema are the major life-threatening complications associated with HF. The purpose of this study is to explore the relationship between the anti-β3-AR autoantibody and the expression of β3-AR in the lungs and heart for both aged patients and rats with HF. Synthetic β3-AR peptides served as the target antigens in ELISA were used to screen the anti-β3-AR autoantibody in aged patients and rats. Two aged rat models were constructed based on aortic banding and sham-operation. The expression of β3-AR mRNA and protein in the lung and heart was measured in intervention and non-intervention groups by Western blot analysis at the baseline, 5th, 7th, 9th and 11th week, respectively. The frequency and titer of anti-β3-AR autoantibody in aged patients and rats with HF were higher than those in the control group (p3-AR mRNA and protein in pulmonary tissues decreased continually from the 7th week (pth week. The expression of β3-AR in myocardial tissues continued to increase after the 9th week (p3-AR mRNA and protein in the BRL group [HF group with BRL37344 (4-[-[2-hydroxy-(3-chlorophenyl)ethyl-amino] phenoxyacetic acid) (a β3-AR agonist) injection] was positively correlated with BRL37344 when compared with non-BRL group (HF group without BRL37344 injection) (p3-AR autoantibody was detected in aged patients and rats with HF. The expression of β3-AR mRNA and protein in pulmonary tissues decreased continually, and began earlier than in the heart, but its expression in myocardial tissues increased continually and could be further promoted by β3-AR agonist.Keywords
This publication has 26 references indexed in Scilit:
- Drug‐like actions of autoantibodies against receptors of the autonomous nervous system and their impact on human heart functionBritish Journal of Pharmacology, 2012
- β-Adrenoceptor stimulation of alveolar fluid clearance is increased in rats with heart failureAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2009
- Involvement of β3-Adrenoceptor in Altered β-Adrenergic Response in Senescent HeartAnesthesiology, 2008
- Oestrogen changed cardiomyocyte contraction and β‐adrenoceptor expression in rat hearts subjected to ischaemia–reperfusionExperimental Physiology, 2008
- Induction of β3-Adrenergic Receptor Functional Expression following Chronic Stimulation with Noradrenaline in Neonatal Rat CardiomyocytesThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Enhanced Inhibition of L-type Ca2+ Current by β3-Adrenergic Stimulation in Failing Rat HeartThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Age-associated reductions in cardiac beta1- and beta2-adrenergic responses without changes in inhibitory G proteins or receptor kinases.Journal of Clinical Investigation, 1998
- STRUCTURE AND FUNCTION OF THE β3-ADRENERGIC RECEPTORAnnual Review of Pharmacology and Toxicology, 1997
- Functional beta3-adrenoceptor in the human heart.Journal of Clinical Investigation, 1996
- Autoantibodies against Cardiac G-Protein-Coupled Receptors Define Different Populations with Cardiomyopathies but Not with HypertensionClinical Immunology and Immunopathology, 1994